Synthesis and activity of new aryl- and heteroaryl-substituted 5,6-dihydro-4H-pyrrolo[1,2-b]pyrazole inhibitors of the transforming growth factor-β type I receptor kinase domain

This publication has 16 references indexed in Scilit:

• Novel and potent transforming growth factor beta type I receptor kinase domain inhibitor: 7-amino 4-(2-pyridin-2-yl-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)-quinolines
  Bioorganic & Medicinal Chemistry Letters, 2004
• Successful shape-Based virtual screening: The discovery of a potent inhibitor of the type I TGFβ receptor kinase (TβRI)
  Bioorganic & Medicinal Chemistry Letters, 2003
• Synthesis and Activity of New Aryl- and Heteroaryl-Substituted Pyrazole Inhibitors of the Transforming Growth Factor-β Type I Receptor Kinase Domain
  Journal of Medicinal Chemistry, 2003
• SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  Molecular Pharmacology, 2002
• Identification of Novel Inhibitors of the Transforming Growth Factor β1 (TGF-β1) Type 1 Receptor (ALK5)
  Journal of Medicinal Chemistry, 2002
• Transforming Growth Factor‐β:A Promising Target for Anti‐Stenosis Therapy
  Cardiovascular Drug Reviews, 2001
• The TGFβ Receptor Activation Process
  Molecular Cell, 2001
• TGF-βs and TGF-β receptors in atherosclerosis
  Cytokine & Growth Factor Reviews, 2000
• TGFβ signals through a heteromeric protein kinase receptor complex
  Cell, 1992
• Production of extracellular matrix by glomerular epithelial cells is regulated by transforming growth factor-β1
  Kidney International, 1992